Daily FNArena News

November’s rate rise was still a close run thing, but the RBA’s “forward-looking” stance provided the need for a preemptive strike.

Incitec Pivot beat market expectations with its FY10 profit result. Positive momentum in fertiliser markets plus improving seasonal conditions suggest further upgrades are possible.

Recent violent moves in physical gold and silver can be attributed to options market-makers desperately trying to hedge.

A glance through the latest expert views and predictions about commodities, with reasons for optimism with respect to commodity prices but some cause for caution on silver.

Seek has shocked the market with a surprise profit downgrade to its education divisions but not all brokers see a problem.

Myer may have disappointed the market with its quarterly sales result but stockbrokers continue to see upside in the stock at current levels.

BTIG market strategist Mike O’Rourke believes investors had become a bit too excited about QE2.

It turns out, ASIC provides a daily update for investors seeking alpha in the Australian share market.

Bluescope’s guidance downgrade has sparked some major earnings forecast downgrades from analysts but they just can’t get past the stock’s longer term value.

HeartWare is developing a device for treating heart failure and Southern Cross Equities rates the stock as a Speculative Buy.